Saturday 17 October 2026
Export OLMA’s income statement to Excel — free account
Olema Pharmaceuticals, Inc.
OLMA Healthcare Biotechnology
In the quarter to June 2026, EPS fell 19.6%, free cash flow fell 54.3% and total debt was flat, each against the same quarter a year earlier.
6.58
0.29
−4.22%
Follow OLMA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
8.86 | 10.88 | 9.95 | 8.03 |
+8 more quarters Free account |
Net Debt/EBITDA |
6.83 | 8.68 | 10.07 | 7.11 | |
Debt/Assets |
0.62% | 0.57% | 0.56% | 0.85% | |
Debt/Equity |
0.01 | 0.01 | 0.01 | 0.01 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.73 | 0.87 | 0.83 | 0.82 | |
Capex/Depreciation |
(2.17) | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.44) | (0.45) | (0.44) | (0.40) | |
Cash per Share |
4.41 | 4.92 | 5.81 | 3.84 | |
Shareholders Equity per Share |
4.12 | 4.67 | 5.50 | 3.59 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.12 | 4.67 | 5.50 | 3.59 | |
Free Cash Flow |
(46.12) | (45.99) | (38.33) | (34.53) | |
Working Capital |
416.86 | 466.06 | 463.65 | 292.67 | |
Capital Expenditures |
(0.22) | — | — | — | |
Net Current Asset Value |
413.86 | 463.06 | 460.58 | 289.36 | |
| Other line items | |||||
Quick Ratio |
8.70 | 10.71 | 9.76 | 7.90 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.44) | (0.45) | (0.44) | (0.40) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
1.30 | 1.94 | 6.86 | 3.08 | |
Average Assets |
434.29 | 470.14 | 492.20 | 291.31 | |
Average Common Equity |
387.90 | 431.97 | 443.76 | 253.20 | |
Capex to Sales |
0.00 | — | — | — |
Columns are period end dates